Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysms
Objective. Left ventricular pseudoaneurysm is a rare but serious complication of acute myocardial infarction. It is under debate whether surgical intervention is mandatory in asymptomatic patients. The aim of this report was to present our experience based on surgical treatment and midterm outcomes of patients with postinfarction left ventricular pseudoaneurysm.
Methods. Eight consecutive patients who underwent left ventricular pseudoaneurysm operation between January 1, 1995, and January 1, 2006, were included in the study. There were 5 male and 3 female patients. Mean age was 62.87 ± 5.03 years. All patients had echocardiography and coronary angiography before the operation. Two anterior and 6 posterior pseudoaneurysms were detected. Left ventricular pseudoaneurysm was repaired with a synthetic patch by the remodeling ventriculoplasty method of Dor in all patients. Coronary revascularization was performed if necessary. Preoperative, operative, and postoperative data were collected from the patient cohorts.
Results. The mean duration from myocardial infarction to diagnosis of the ventricular septal rupture was 13.5 ± 12 days. Additional coronary artery bypass surgery was performed with a median of 1.2 grafts in 5 patients (62.5%). The mean postoperative mechanic ventilator support time was 20.12 ± 29.22 hours. Overall 30-day mortality was 12.5% with 1 patient death. The mean intensive care unit stay was 3.75 ± 2.1 days. The late mortality rate was 12.5%. In the follow-up period (mean, 30.66 ± 16.86 months), of the 6 patients who were alive, 5 were in New York Heart Association class I or II and 1 was in class III because of pre-existing low left ventricular ejection fraction. Transthoracic echocardiography showed good left ventricular configurations without a false aneurysm together with increases in the ejection fractions.
Conclusion. Prompt diagnosis and early surgical intervention is essential for patients with large or expanding left ventricular pseudoaneurysms due to the high propensity of fatal rupture. Associated coronary artery bypass grafting may reduce early mortality of patients with left ventricular pseudoaneurysm by resuscitating the ischemic myocardium.
Brown SL, Gropler RJ, Harris KM. 1997. Distinguishing left ventricular aneurysm from pseudoaneurysm. A review of the literature. Chest 111:1403-9.nCsapo K, Voith L, Szuk T, Edes I, Kereiakes DJ. 1997. Postinfarction left ventricular pseudoaneurysm. Clin Cardiol 20:898-903.nFigueras J, Cortadellas J, Domingo E, Rodes S, Castell J, Soler J. 2001. Survival following self-limited left ventricular free wall rupture during myocardial infarction. Management differences between patients with or without pseudoaneurysm formation. Int J Cardiol 79:103-11.nFrances C, Romero A, Grady D. 1998. Left ventricular pseudoaneurysm. J Am Coll Cardiol 32:557-61.nHirasawa Y, Miyauchi T, Sawamura T, Tayika H. 2004. Giant left ventricular pseudoaneurysm after mitral valve replacement and myocardial infarction. Ann Thorac Surg 78:1823-5.nKoçak H, Becit N, Ceviz M, Ünlü Y. 2003. Left ventricular pseudoaneurysm after myocardial infarction. Heart Vessels 18:160-2.nKomeda M, David TE. 1993. Surgical treatment of postinfarction false aneurysm of the left ventricle. J Thorac Cardiovasc Surg 106:1189-91.nMoreno R, Gordillo E, Zamorano J, et al. 2003. Long term outcome of patients with postinfarction left ventricular pseudoaneurysm. Heart 89:1144-6.nMilojevic P, Nescovic V, Vucovic M, Nezic D, Djukanovic B. 2004. Surgical repair of a leaking double postinfarction left ventricular pseudoaneurysm. J Thorac Cardiovasc Surg 128:765-7.nPretre R, Linka A, Jenni R, Turina MI. 2000. Surgical treatment of acquired left ventricular pseudoaneurysms. Ann Thorac Surg 70:53-7.nRittenhouse EA, Sauvage LR, Mansfield PB, Smith JC, Davis CC, Hall DG. 1979. False aneurysm of the left ventricle. Report of four cases and review of surgical management. Ann Surg 189:409-15.nStevenson WG, Linssen GC, Havenith MG, Brugada P, Wellens HJ. 1989. The spectrum of death after myocardial infarction: a necropsy study. Am Heart J 118:1182-8.nVarvarigos N, Koletsis E, Zafiropoulos A, Papaioannou H, Migdalis I. 2005. A case of left ventricular pseudoaneurysm with long survival and congestive heart failure as first presentation. Case report and review of the literature. Med Sci Monit 11:CS69-73.nYeo TC, Malouf JF, Oh JK, Seward JB. 1998. Clinical profile and outcome in 52 patients with cardiac pseudoaneurysm. Ann Intern Med 128:299-305.nYeo TC, Malouf JF, Reeder GS, Oh JK. 1999. Clinical characteristics and outcome in postinfarction pseudoaneurysm. Am J Cardiol 8:592-5, A8.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).